We have received your feedback.Thank you for taking your time in view of your busy schedule.
Chinese pharma company announces partnership with Canadian biotech firm
Chinese biopharmaceutical company Everest Medicines Ltd announced on Monday a strategic partnership with Canadian biotechnology company Providence Therapeutics Holdings Inc in an effort to develop mRNA COVID-19 vaccines.
Under the partnership, Everest is licensed rights to Providence's mRNA COVID-19 vaccine candidates in Asian emerging markets, including China, Southeast Asia and Pakistan. The two parties will also establish a broad, strategic partnership to develop mRNA products globally, leveraging Providence's cutting-edge mRNA technology platform.
Invite your friends, colleagues and business partners to
join us to get news, analysis and database of Chinese market.Invite Now FOR FREE >